Mitophagy and Alzheimer's Disease: Cellular and Molecular Mechanisms

Trends in Neurosciences

Volumn 40, Issue 3, 2017, Pages 151-166

  Kerr, Jesse S ^a   Adriaanse, Bryan A ^b   Greig, Nigel H ^a   Mattson, Mark P ^a,c   Cader, M Zameel ^b   Bohr, Vilhelm A ^a,d   Fang, Evandro F ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BRAIN PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN DYSFUNCTION; BRAIN FUNCTION; BRAIN MITOCHONDRION; DNA DAMAGE; HUMAN; INDUCED PLURIPOTENT STEM CELL; MITOCHONDRIAL DYNAMICS; MITOPHAGY; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; AUTOPHAGY; METABOLISM; MITOCHONDRION; PHYSIOLOGY;

ALZHEIMER DISEASE; ANIMALS; AUTOPHAGY; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DEGRADATION;

EID: 85012907718     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2017.01.002     Document Type: Review

References (123)

1. 1 Citron, M., Alzheimer's disease: strategies for disease modification. Nat. Rev. Drug Discov. 9 (2010), 387–398.
2. 2 Hampel, H., et al. The future of Alzheimer's disease: the next 10 years. Prog. Neurobiol. 95 (2011), 718–728.
3. 3 Perry, R.J., et al. The nature and staging of attention dysfunction in early (minimal and mild) Alzheimer's disease: relationship to episodic and semantic memory impairment. Neuropsychologia 38 (2000), 252–271.
4. 4 Braak, H., Braak, E., Staging of Alzheimer's disease-related neurofibrillary changes. Neurobiol. Aging 16 (1995), 271–278 discussion 278–284.
5. 5 Price, J.L., et al. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging 12 (1991), 295–312.
6. 6 Kapogiannis, D., Mattson, M.P., Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol. 10 (2011), 187–198.
7. 7 Blass, J.P., Gibson, G.E., The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev. Neurol. (Paris) 147 (1991), 513–525.
8. 8 Swerdlow, R.H., Khan, S.M., A “mitochondrial cascade hypothesis” for sporadic Alzheimer's disease. Med. Hypotheses 63 (2004), 8–20.
9. 9 Wallace, D.C., Mitochondrial diseases in man and mouse. Science 283 (1999), 1482–1488.
10. 10 Mattson, M.P., et al. Mitochondria in neuroplasticity and neurological disorders. Neuron 60 (2008), 748–766.
11. 11 Cheng, A., et al. Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines. Nat. Commun., 3, 2012, 1250.
12. 12 Marosi, K., Mattson, M.P., BDNF mediates adaptive brain and body responses to energetic challenges. Trends Endocrinol. Metab. 25 (2014), 89–98.
13. 13 Cheng, A., et al. Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges. Cell Metab. 23 (2016), 128–142.
14. 14 Bezprozvanny, I., Mattson, M.P., Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci. 31 (2008), 454–463.
15. 15 Menzies, F.M., et al. Compromised autophagy and neurodegenerative diseases. Nat. Rev. Neurosci. 16 (2015), 345–357.
16. 16 Cai, Q., Tammineni, P., Alterations in mitochondrial quality control in Alzheimer's disease. Front. Cell. Neurosci., 10, 2016, 24.
17. 17 Fang, E.F., et al. Nuclear DNA damage signalling to mitochondria in ageing. Nat. Rev. Mol. Cell Biol. 17 (2016), 308–321.
18. 18 Rubinsztein, D.C., Autophagy and aging. Cell 146 (2011), 682–695.
19. 19 Palikaras, K., et al. Coordination of mitophagy and mitochondrial biogenesis during ageing in C. elegans. Nature 521 (2015), 525–528.
20. 20 Youle, R.J., Narendra, D.P., Mechanisms of mitophagy. Nat. Rev. Mol. Cell Biol. 12 (2011), 9–14.
21. 21 Lazarou, M., et al. The ubiquitin kinase PINK1 recruits autophagy receptors to induce mitophagy. Nature 524 (2015), 309–314.
22. 22 Geisler, S., et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat. Cell Biol. 12 (2010), 119–131.
23. 23 Sterky, F.H., et al. Impaired mitochondrial transport and Parkin-independent degeneration of respiratory chain-deficient dopamine neurons in vivo. Proc. Natl. Acad. Sci. U. S. A. 108 (2011), 12937–12942.
24. 24 Rakovic, A., et al. Phosphatase and tensin homolog (PTEN)-induced putative kinase 1 (PINK1)-dependent ubiquitination of endogenous Parkin attenuates mitophagy: study in human primary fibroblasts and induced pluripotent stem cell-derived neurons. J. Biol. Chem. 288 (2013), 2223–2237.
25. 25 Strappazzon, F., et al. AMBRA1 is able to induce mitophagy via LC3 binding, regardless of PARKIN and p62/SQSTM1. Cell Death Differ. 22 (2015), 419–432.
26. 26 Chen, M., et al. Mitophagy receptor FUNDC1 regulates mitochondrial dynamics and mitophagy. Autophagy 12 (2016), 689–702.
27. 27 Sandoval, H., et al. Essential role for Nix in autophagic maturation of erythroid cells. Nature 454 (2008), 232–235.
28. 28 Gao, F., et al. The mitochondrial protein BNIP3L is the substrate of PARK2 and mediates mitophagy in PINK1/PARK2 pathway. Hum. Mol. Genet. 24 (2015), 2528–2538.
29. 29 Mattson, M.P., Energy intake and exercise as determinants of brain health and vulnerability to injury and disease. Cell Metab. 16 (2012), 706–722.
30. 30 Spilman, P., et al. Inhibition of mTOR by rapamycin abolishes cognitive deficits and reduces amyloid-β levels in a mouse model of Alzheimer's disease. PLoS One, 5, 2010, e9979.
31. 31 Geisler, J.G., et al. DNP, mitochondrial uncoupling, and neuroprotection: a little dab'll do ya. Alzheimers Dement., 2016, 10.1016/j.jalz.2016.08.001 Published online September 4, 2016.
32. 32 Stranahan, A.M., et al. Diet-induced insulin resistance impairs hippocampal synaptic plasticity and cognition in middle-aged rats. Hippocampus 18 (2008), 1085–1088.
33. 33 Jung, H.S., Lee, M.S., Role of autophagy in diabetes and mitochondria. Ann. N. Y. Acad. Sci. 1201 (2010), 79–83.
34. 34 Katsouri, L., et al. PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-beta generation by reducing β-secretase in an Alzheimer's disease model. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 12292–12297.
35. 35 Mattson, M.P., Pathways towards and away from Alzheimer's disease. Nature 430 (2004), 631–639.
36. 36 Cao, D., et al. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J. Biol. Chem. 282 (2007), 36275–36282.
37. 37 Luchsinger, J.A., et al. Caloric intake and the risk of Alzheimer disease. Arch. Neurol. 59 (2002), 1258–1263.
38. 38 Halagappa, V.K., et al. Intermittent fasting and caloric restriction ameliorate age-related behavioral deficits in the triple-transgenic mouse model of Alzheimer's disease. Neurobiol. Dis. 26 (2007), 212–220.
39. 39 Schafer, M.J., et al. Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice. Neurobiol. Aging 36 (2015), 1293–1302.
40. 40 Sims-Robinson, C., How does diabetes accelerate Alzheimer disease pathology. Nat. Rev. Neurol. 6 (2010), 551–559.
41. 41 Walker, J.M., Harrison, F.E., Shared neuropathological characteristics of obesity, type 2 diabetes and Alzheimer's disease: impacts on cognitive decline. Nutrients 7 (2015), 7332–7357.
42. 42 Yao, J., et al. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 14670–14675.
43. 43 Leuner, K., et al. Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes. Mol. Neurobiol. 46 (2012), 194–204.
44. 44 Mao, P., et al. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid beta production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension. Hum. Mol. Genet. 21 (2012), 2973–2990.
45. 45 Esposito, L., et al. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J Neurosci. 26 (2006), 5167–5179.
46. 46 Chen, L., et al. NLRP3 inflammasome activation by mitochondrial reactive oxygen species plays a key role in long-term cognitive impairment induced by paraquat exposure. Neurobiol. Aging 36 (2015), 2533–2543.
47. 47 Gwon, A.R., et al. Oxidative lipid modification of nicastrin enhances amyloidogenic γ-secretase activity in Alzheimer's disease. Aging Cell 11 (2012), 559–568.
48. 48 Buee, L., et al. Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33 (2000), 95–130.
49. 49 Gong, C.X., et al. Targeting Tau protein in Alzheimer's disease. Drugs Aging 27 (2010), 351–365.
50. 50 Mattson, M.P., et al. 4-Hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein Tau. Neuroreport 8 (1997), 2275–2281.
51. 51 Hoglinger, G.U., et al. The mitochondrial complex I inhibitor rotenone triggers a cerebral tauopathy. J. Neurochem. 95 (2005), 930–939.
52. 2 causes mitochondrial transport defects and Tau hyperphosphorylation. EMBO J. 33 (2014), 1011–1026.
53. 53 Melov, S., et al. Mitochondrial oxidative stress causes hyperphosphorylation of Tau. PLoS One, 2, 2007, e536.
54. 54 Hou, Y., et al. Permeability transition pore-mediated mitochondrial superoxide flashes mediate an early inhibitory effect of amyloid β1-42 on neural progenitor cell proliferation. Neurobiol. Aging 35 (2014), 975–989.
55. 55 Casley, C.S., et al. β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80 (2002), 91–100.
56. 56 Leuner, K., et al. Mitochondrion-derived reactive oxygen species lead to enhanced amyloid beta formation. Antioxid. Redox Signal. 16 (2012), 1421–1433.
57. 57 Du, H., et al. Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 18670–18675.
58. 58 Keller, J.N., et al. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid β-peptide: role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69 (1997), 273–284.
59. 59 Lewis, J., et al. Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) Tau protein. Nat. Genet., 26, 2000, 127.
60. 60 David, D.C., et al. Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L Tau transgenic mice. J. Biol. Chem. 280 (2005), 23802–23814.
61. 61 Hu, Y., et al. Tau accumulation impairs mitophagy via increasing mitochondrial membrane potential and reducing mitochondrial Parkin. Oncotarget 7 (2016), 17356–17368.
62. 62 Amadoro, G., et al. A NH2 Tau fragment targets neuronal mitochondria at AD synapses: possible implications for neurodegeneration. J. Alzheimers Dis. 21 (2010), 445–470.
63. 63 Nixon, R.A., The role of autophagy in neurodegenerative disease. Nat. Med. 19 (2013), 983–997.
64. 64 Ashrafi, G., Schwarz, T.L., PINK1- and PARK2-mediated local mitophagy in distal neuronal axons. Autophagy 11 (2015), 187–189.
65. 65 Bordi, M., et al. Autophagy flux in CA1 neurons of Alzheimer hippocampus: increased induction overburdens failing lysosomes to propel neuritic dystrophy. Autophagy 2016 (2016), 1–17.
66. 66 Goetzl, E.J., et al. Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease. Neurology 85 (2015), 40–47.
67. 67 Nixon, R.A., Neurodegenerative lysosomal disorders: a continuum from development to late age. Autophagy 4 (2008), 590–599.
68. 68 Boland, B., et al. Autophagy induction and autophagosome clearance in neurons: relationship to autophagic pathology in Alzheimer's disease. J. Neurosci. 28 (2008), 6926–6937.
69. 69 Liu, D., et al. Nicotinamide forestalls pathology and cognitive decline in Alzheimer mice: evidence for improved neuronal bioenergetics and autophagy procession. Neurobiol. Aging 34 (2013), 1564–1580.
70. 70 Lee, J.H., et al. Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141 (2010), 1146–1158.
71. 71 Coffey, E.E., et al. Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer's disease-linked presenilin 1 A246E mutation can be reversed with cAMP. Neuroscience 263 (2014), 111–124.
72. 72 Ye, X., et al. Parkin-mediated mitophagy in mutant hAPP neurons and Alzheimer's disease patient brains. Hum. Mol. Genet. 24 (2015), 2938–2951.
73. 73 Mozdy, A.D., et al. Dnm1p GTPase-mediated mitochondrial fission is a multi-step process requiring the novel integral membrane component Fis1p. J. Cell Biol. 151 (2000), 367–380.
74. 74 Labrousse, A.M., et al. C. elegans dynamin-related protein DRP-1 controls severing of the mitochondrial outer membrane. Mol. Cell 4 (1999), 815–826.
75. 75 Duvezin-Caubet, S., et al. OPA1 processing reconstituted in yeast depends on the subunit composition of the m-AAA protease in mitochondria. Mol. Biol. Cell 18 (2007), 3582–3590.
76. 76 Burte, F., et al. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat. Rev. Neurol. 11 (2015), 11–24.
77. 77 DuBoff, B., et al. Why size matters – balancing mitochondrial dynamics in Alzheimer's disease. Trends Neurosci. 36 (2013), 325–335.
78. 78 Cho, D.H., et al. S-nitrosylation of Drp1 mediates β-amyloid-related mitochondrial fission and neuronal injury. Science 324 (2009), 102–105.
79. 79 Wang, X., et al. Dynamin-like protein 1 reduction underlies mitochondrial morphology and distribution abnormalities in fibroblasts from sporadic Alzheimer's disease patients. Am. J. Pathol. 173 (2008), 470–482.
80. 80 Rice, A.C., et al. Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer's disease hippocampi. J. Alzheimers Dis. 40 (2014), 319–330.
81. 81 Fang, E.F., et al. Nuclear DNA damage signalling to mitochondria in ageing. Nat. Rev. Mol. Cell Biol. 17 (2016), 308–321.
82. 82 Julien, C., et al. Sirtuin 1 reduction parallels the accumulation of Tau in Alzheimer disease. J. Neuropathol. Exp. Neurol. 68 (2009), 48–58.
83. + replenishment improves lifespan and healthspan in ataxia telangiectasia models via mitophagy and DNA repair. Cell Metabolism. 24 (2016), 566–581.
84. +/SIRT1 reduction. Cell 157 (2014), 882–896.
85. 85 Tseng, A.H., et al. SIRT3 deacetylates FOXO3 to protect mitochondria against oxidative damage. Free Radic. Biol. Med. 63 (2013), 222–234.
86. 86 Yang, W., et al. Mitochondrial Sirt3 expression is decreased in APP/PS1 double transgenic mouse model of Alzheimer's disease. Neurochem. Res. 40 (2015), 1576–1582.
87. 87 Young-Collier, K.J., The dying of the light: mitochondrial failure in Alzheimer's disease. J. Alzheimers Dis. 28 (2012), 771–781.
88. + replenishment. Brain 138 (2015), 992–1008.
89. + in aging, metabolism, and neurodegeneration. Science 350 (2015), 1208–1213.
90. 90 Strosznajder, J.B., et al. Poly(ADP-ribose) polymerase-1 in amyloid beta toxicity and Alzheimer's disease. Mol. Neurobiol. 46 (2012), 78–84.
91. 91 Chow, H.M., Herrup, K., Genomic integrity and the ageing brain. Nat. Rev. Neurosci. 16 (2015), 672–684.
92. 92 Sykora, P., et al. DNA polymerase beta deficiency leads to neurodegeneration and exacerbates Alzheimer disease phenotypes. Nucleic Acids Res. 43 (2015), 943–959.
93. 93 Martire, S., et al. Bioenergetic impairment in animal and cellular models of Alzheimer's disease: PARP-1 inhibition rescues metabolic dysfunctions. J. Alzheimers Dis. 54 (2016), 307–324.
94. 94 Blacher, E., et al. Alzheimer's disease pathology is attenuated in a CD38-deficient mouse model. Ann. Neurol. 78 (2015), 88–103.
95. 95 Hou, Y., et al. Genome instability in Alzheimer disease. Mech. Ageing Dev., 2016, 10.1016/j.mad.2016.04.005 Published online April 20, 2016.
96. 96 Martire, S., et al. PARP-1 involvement in neurodegeneration: a focus on Alzheimer's and Parkinson's diseases. Mech. Ageing Dev. 146–148 (2015), 53–64.
97. 97 Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 (2006), 663–676.
98. 98 Moran, N., Banking iPS cells. Nat. Biotech., 31, 2013 11–11.
99. 99 Jucker, M., The benefits and limitations of animal models for translational research in neurodegenerative diseases. Nat. Med. 16 (2010), 1210–1214.
100. 100 Handel, A.E., et al. Assessing similarity to primary tissue and cortical layer identity in induced pluripotent stem cell-derived cortical neurons through single-cell transcriptomics. Hum. Mol. Genet. 25 (2016), 989–1000.
101. 101 Zhang, Y., et al. Rapid single-step induction of functional neurons from human pluripotent stem cells. Neuron 78 (2013), 785–798.
102. 102 Miller, J.D., et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13 (2013), 691–705.
103. 103 Sang-Ging Ong, W.H.L., Human induced pluripotent stem cells reveal mitophagy as an essential process against diabetic cardiomyopathy. Circ. Res., 117, 2015, A246.
104. 104 Mayer, G., Effects of changes in peripheral and cerebral glucose metabolism on locomotor activity, learning and memory in adult male rats. Brain Res. 532 (1990), 95–100.
105. 105 Salkovic-Petrisic, M., et al. What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer's disease, about the therapeutic strategies in Alzheimer's research. J. Neural. Transm. (Vienna) 120 (2013), 233–252.
106. 106 Salkovic-Petrisic, M., et al. Cerebral amyloid angiopathy in streptozotocin rat model of sporadic Alzheimer's disease: a long-term follow up study. J. Neural. Transm. (Vienna) 118 (2011), 765–772.
107. 107 Stefanova, N.A., et al. Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease. Cell Cycle 13 (2014), 898–909.
108. 108 Stefanova, N.A., et al. Amyloid accumulation is a late event in sporadic Alzheimer's disease-like pathology in nontransgenic rats. Oncotarget 6 (2015), 1396–1413.
109. 109 Cheng, X.R., et al. The behavioral, pathological and therapeutic features of the senescence-accelerated mouse prone 8 strain as an Alzheimer's disease animal model. Ageing Res. Rev. 13 (2014), 13–37.
110. −/− mice as an age-related model of cognitive impairment and Alzheimer's disease. Mol. Brain, 8, 2015, 27.
111. 111 Longo, V.D., Mattson, M.P., Fasting: molecular mechanisms and clinical applications. Cell Metab. 19 (2014), 181–192.
112. 112 Mattson, M.P., Lifelong brain health is a lifelong challenge: from evolutionary principles to empirical evidence. Ageing Res. Rev. 20 (2015), 37–45.
113. 113 Alirezaei, M., et al. Short-term fasting induces profound neuronal autophagy. Autophagy 6 (2010), 702–710.
114. 114 Fernandez-Moriano, C., et al. Mitochondria-targeted protective compounds in Parkinson's and Alzheimer's diseases. Oxid. Med. Cell Longev., 2015, 2015, 408927.
115. 1–42-induced rat model of Alzheimer's disease. Free Radic. Res. 48 (2014), 146–158.
116. 116 Gong, B., et al. Nicotinamide riboside restores cognition through an upregulation of proliferator-activated receptor-γ coactivator 1α regulated β-secretase 1 degradation and mitochondrial gene expression in Alzheimer's mouse models. Neurobiol. Aging 34 (2013), 1581–1588.
117. 117 Duan, W., Mattson, M.P., Dietary restriction and 2-deoxyglucose administration improve behavioral outcome and reduce degeneration of dopaminergic neurons in models of Parkinson's disease. J. Neurosci. Res. 57 (1999), 195–206.
118. 118 Yao, J., et al. 2-Deoxy-D-glucose treatment induces ketogenesis, sustains mitochondrial function, and reduces pathology in female mouse model of Alzheimer's disease. PLoS One, 6, 2011, e21788.
119. 119 Ryu, D., et al. Urolithin A induces mitophagy and prolongs lifespan in C. elegans and increases muscle function in rodents. Nat. Med. 22 (2016), 879–888.
120. 120 Sun, N., et al. Measuring in vivo mitophagy. Mol Cell 60 (2015), 685–696.
121. 121 Morselli, E., et al. Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J. Cell Biol. 192 (2011), 615–629.
122. 122 Nakatogawa, H., et al. Atg8, a ubiquitin-like protein required for autophagosome formation, mediates membrane tethering and hemifusion. Cell 130 (2007), 165–178.
123. 123 Nakatogawa, H., et al. Dynamics and diversity in autophagy mechanisms: lessons from yeast. Nat. Rev. Mol. Cell Biol. 10 (2009), 458–467.